EUVIMEDEUVIMED entdecken
Crossref

BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use

Sinthia Vidal Cañas, Elias Chuki

Clinical Thyroidology® · 01.03.2026 · 38 (3) · 87-91

DOI: 10.1177/23299711261436475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 22.04.2026. Verfasst von Sinthia Vidal Cañas und 1 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cañas, S. V., & Chuki, E. (2026). BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use. Clinical Thyroidology®, 38(3), 87-91. https://doi.org/10.1177/23299711261436475

Vancouver

Cañas SV, Chuki E. BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use. Clinical Thyroidology®. 2026;38(3):87-91. doi:10.1177/23299711261436475

BibTeX
@article{Caas2026,
  author = {Cañas, Sinthia Vidal and Chuki, Elias},
  title = {BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use},
  journal = {Clinical Thyroidology®},
  year = {2026},
  volume = {38},
  number = {3},
  pages = {87--91},
  doi = {10.1177/23299711261436475}
}
Kostenlos starten →